In vivo MR and fluorescence dual-modality imaging of atherosclerosis characteristics in mice using profilin-1 targeted magnetic nanoparticles

Theranostics

Volumn 6, Issue 2, 2016, Pages 272-286

  Wang, Yabin ^a,b   Chen, Jiangwei ^b   Yang, Bo ^a   Qiao, Hongyu ^b   Gao, Lei ^a   Su, Tao ^b   Ma, Sai ^b   Zhang, Xiaotian ^b   Li, Xiujuan ^b   Liu, Gang ^c   Cao, Jianbo ^c   Chen, Xiaoyuan ^d   Chen, Yundai ^a   Cao, Feng ^a,b  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c XIAMEN UNIVERSITY   (China)

^d NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING   (United States)

Author keywords

Atherosclerosis; DMSA Fe3O4 nanoparticles; Molecular imaging; Profilin 1

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; ATORVASTATIN; MAGNETIC NANOPARTICLE; OXIDIZED LOW DENSITY LIPOPROTEIN; PROFILIN; PROFILIN 1; SMALL INTERFERING RNA; SUCCIMER IRON OXIDE NANOPARTICLE; UNCLASSIFIED DRUG; CARBOCYANINE; CY5.5 CYANINE DYE; FERRIC ION; FERRIC OXIDE; MAGNETITE NANOPARTICLE; PROTEIN BINDING; SUCCIMER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ATHEROSCLEROSIS; ARTICLE; BIOCOMPATIBILITY; CAROTID ATHEROSCLEROSIS; CELL MIGRATION; CELL PROLIFERATION; CHOLESTEROL DIET; CONTROLLED STUDY; DESCENDING AORTA; DRUG ACCUMULATION; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG EFFECT; DRUG STABILITY; EX VIVO STUDY; FLUORESCENCE IMAGING; IN VITRO STUDY; IN VIVO STUDY; LIPID DIET; MALE; MOLECULAR IMAGING; MOUSE; MULTIMODAL IMAGING; NEAR INFRARED FLUORESCENCE IMAGING; NON INVASIVE MEASUREMENT; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; ANIMAL; ATHEROSCLEROSIS; CAROTID ARTERY; CHEMISTRY; CYTOLOGY; METABOLISM; PATHOLOGY; PHYSIOLOGY; PROCEDURES; SMOOTH MUSCLE CELL;

ANIMALS; ATHEROSCLEROSIS; CARBOCYANINES; CAROTID ARTERIES; CELL PROLIFERATION; FERRIC COMPOUNDS; MAGNETIC RESONANCE IMAGING; MAGNETITE NANOPARTICLES; MALE; MICE; MULTIMODAL IMAGING; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; OPTICAL IMAGING; PROFILINS; PROTEIN BINDING; SUCCIMER;

EID: 84954233952     PISSN: None     EISSN: 18387640     Source Type: Journal    
DOI: 10.7150/thno.13350     Document Type: Article

References (25)

1. Erbel R, Budoff M. Improvement of cardiovascular risk prediction using coronary imaging: subclinical atherosclerosis: the memory of lifetime risk factor exposure. European heart journal. 2012;33:1201-13.
2. Wang H, Eitzman DT. Acute myocardial infarction leads to acceleration of atherosclerosis. Atherosclerosis. 2013;229:18-22.
3. Foin N, Evans P, Krams R. Atherosclerosis: cell biology and lipoproteins-new developments in imaging of inflammation of the vulnerable plaque. Current opinion in lipidology. 2008;19:98-100.
4. Chan JM, Monaco C, Wylezinska-Arridge M, Tremoleda JL, Gibbs RG. Imaging of the vulnerable carotid plaque: biological targeting of inflammation in atherosclerosis using iron oxide particles and MRI. European journal of vascular and endovascular surgery: the official journal of the European Society for Vascular Surgery. 2014;47:462-9.
5. Wildgruber M, Swirski FK, Zernecke A. Molecular imaging of inflammation in atherosclerosis. Theranostics. 2013;3:865-84.
6. von Bary C, Makowski M, Preissel A, Keithahn A, Warley A, Spuentrup E, et al. MRI of coronary wall remodeling in a swine model of coronary injury using an elastin-binding contrast agent. Circulation Cardiovascular imaging. 2011;4:147-55.
7. Romeo GR, Moulton KS, Kazlauskas A. Attenuated expression of profilin-1 confers protection from atherosclerosis in the LDL receptor null mouse. Circulation research. 2007;101:357-67.
8. Romeo GR, Pae M, Eberle D, Lee J, Shoelson SE. Profilin-1 haploinsufficiency protects against obesity-associated glucose intolerance and preserves adipose tissue immune homeostasis. Diabetes. 2013;62:3718-26.
9. Elnakish MT, Hassanain HH, Janssen PM. Vascular remodeling-associated hypertension leads to left ventricular hypertrophy and contractile dysfunction in profilin-1 transgenic mice. Journal of cardiovascular pharmacology. 2012;60:544-52.
10. Adams KE, Ke S, Kwon S, Liang F, Fan Z, Lu Y, et al. Comparison of visible and near-infrared wavelength-excitable fluorescent dyes for molecular imaging of cancer. Journal of biomedical optics. 2007;12:024017.
11. Kim DE, Kim JY, Schellingerhout D, Shon SM, Jeong SW, Kim EJ, et al. Molecular imaging of cathepsin B proteolytic enzyme activity reflects the inflammatory component of atherosclerotic pathology and can quantitatively demonstrate the antiatherosclerotic therapeutic effects of atorvastatin and glucosamine. Molecular imaging. 2009;8:291-301.
12. Osborn EA, Jaffer FA. The advancing clinical impact of molecular imaging in CVD. JACC Cardiovascular imaging. 2013;6:1327-41.
13. Ding Z, Bae YH, Roy P. Molecular insights on context-specific role of profilin-1 in cell migration. Cell adhesion & migration. 2012;6:442-9.
14. Song B, Jin H, Yu X, Zhang Z, Yu H, Ye J, et al. Angiotensin-converting enzyme 2 attenuates oxidative stress and VSMC proliferation via the JAK2/STAT3/SOCS3 and profilin-1/MAPK signaling pathways. Regulatory peptides. 2013;185:44-51.
15. Lu T, Wen S, Cui Y, Ju SH, Li KC, Teng GJ. Near-infrared fluorescence imaging of murine atherosclerosis using an oxidized low density lipoprotein-targeted fluorochrome. The international journal of cardiovascular imaging. 2014;30:221-31.
16. Eckert MA, Vu PQ, Zhang K, Kang D, Ali MM, Xu C, et al. Novel molecular and nanosensors for in vivo sensing. Theranostics. 2013;3:583-94.
17. Chakravarty R, Goel S, Cai W. Nanobody: the "magic bullet" for molecular imaging? Theranostics. 2014;4:386-98.
18. Segers FM, den Adel B, Bot I, van der Graaf LM, van der Veer EP, Gonzalez W, et al. Scavenger receptor-AI-targeted iron oxide nanoparticles for in vivo MRI detection of atherosclerotic lesions. Arteriosclerosis, thrombosis, and vascular biology. 2013;33:1812-9.
19. Bruckman MA, Jiang K, Simpson EJ, Randolph LN, Luyt LG, Yu X, et al. Dual-modal magnetic resonance and fluorescence imaging of atherosclerotic plaques in vivo using VCAM-1 targeted tobacco mosaic virus. Nano letters. 2014;14:1551-8.
20. Kim WY, Stuber M, Bornert P, Kissinger KV, Manning WJ, Botnar RM. Three-dimensional black-blood cardiac magnetic resonance coronary vessel wall imaging detects positive arterial remodeling in patients with nonsignificant coronary artery disease. Circulation. 2002;106:296-9.
21. Yeon SB, Sabir A, Clouse M, Martinezclark PO, Peters DC, Hauser TH, et al. Delayed-enhancement cardiovascular magnetic resonance coronary artery wall imaging: comparison with multislice computed tomography and quantitative coronary angiography. Journal of the American College of Cardiology. 2007;50:441-7.
22. Phinikaridou A, Andia ME, Lacerda S, Lorrio S, Makowski MR, Botnar RM. Molecular MRI of atherosclerosis. Molecules. 2013;18:14042-69.
23. Chen W, Cormode DP, Vengrenyuk Y, Herranz B, Feig JE, Klink A, et al. Collagen-specific peptide conjugated HDL nanoparticles as MRI contrast agent to evaluate compositional changes in atherosclerotic plaque regression. JACC Cardiovascular imaging. 2013;6:373-84.
24. Nahrendorf M, Waterman P, Thurber G, Groves K, Rajopadhye M, Panizzi P, et al. Hybrid in vivo FMT-CT imaging of protease activity in atherosclerosis with customized nanosensors. Arteriosclerosis, thrombosis, and vascular biology. 2009;29:1444-51.
25. Dimastromatteo J, Broisat A, Perret P, Ahmadi M, Boturyn D, Dumy P, et al. In vivo molecular imaging of atherosclerotic lesions in ApoE-/-mice using VCAM-1-specific, 99mTc-labeled peptidic sequences. Journal of nuclear medicine: official publication, Society of Nuclear Medicine. 2013;54:1442-9.